| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.77B | 19.76B | 18.61B | 19.06B | 19.76B | 17.39B |
| Gross Profit | 8.39B | 9.24B | 8.29B | 8.56B | 7.63B | 7.82B |
| EBITDA | 2.52B | 3.16B | 2.39B | 2.92B | 2.49B | 2.83B |
| Net Income | 1.72B | 2.30B | 1.72B | 1.94B | 1.59B | 1.87B |
Balance Sheet | ||||||
| Total Assets | 23.25B | 26.23B | 23.29B | 22.63B | 19.26B | 17.32B |
| Cash, Cash Equivalents and Short-Term Investments | 15.38B | 16.86B | 14.69B | 13.39B | 10.20B | 8.45B |
| Total Debt | 171.00M | 97.00M | 191.00M | 133.00M | 157.00M | 157.00M |
| Total Liabilities | 11.15B | 12.97B | 11.00B | 11.49B | 9.65B | 8.84B |
| Stockholders Equity | 12.08B | 13.25B | 12.27B | 11.12B | 9.60B | 8.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.43B | 1.84B | 3.55B | 2.20B | 2.03B |
| Operating Cash Flow | 0.00 | 3.60B | 2.04B | 3.64B | 2.30B | 2.11B |
| Investing Cash Flow | 0.00 | -10.17B | -237.00M | -57.00M | -309.00M | -495.00M |
| Financing Cash Flow | 0.00 | -1.27B | -507.00M | -397.00M | -252.00M | -481.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥15.97B | 21.91 | ― | 0.17% | 31.80% | 31.11% | |
73 Outperform | ¥32.84B | 16.59 | 19.71% | 3.09% | 6.21% | 33.18% | |
70 Outperform | ¥41.06B | 23.65 | ― | 0.90% | 25.23% | 46.99% | |
68 Neutral | ¥23.55B | 119.61 | ― | ― | 19.37% | 23.43% | |
68 Neutral | ¥31.04B | 27.58 | ― | 0.39% | 27.56% | 36.05% | |
62 Neutral | ¥44.62B | 50.91 | ― | ― | 43.11% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |